About AIDS

What's the latest scoop in HIV/AIDS research? You can bet that if it's important, it was announced at February's 11th annual Conference on Retroviruses and Opportunistic Diseases, one of the premier HIV meetings in the world. To find out what went on at the conference, come have dinner with Dr. Bob Wallace, as he gives a Retrovirus Conference update on Thursday evening, April 8.

Dr. Wallace has treated people with HIV in his medical practice in Tampa Bay, Fla., for more than 18 years. Presently, he is the associate director of medical affairs at Gilead Sciences, makers of the one-pill-a-day nukes Viread and Emtriva.

CROD, co-sponsored by the National Institute of Allergy and Infectious Diseases and the Centers for Disease Control and Prevention, is a scientifically focused meeting of the world's leading HIV/AIDS researchers. Its goal is to provide a forum for translating laboratory, clinical, and epidemiological research into useful medical applications.

This is the third program in ASA's 2004 Dining With the Doctor series, addressing the questions that people with HIV ask most frequently. Simultaneous Spanish translation will be provided.

The free dinner and program will begin at 6:30pm at AIDS Services of Austin, 7215 Cameron, just north of St. Johns. Clients of ASA, ALLGO, CARE, and Women Rising will be eligible to participate in a drawing for $20 gift cards. The evening is being generously underwritten by Gilead Sciences.

Virology, immunology, vaccines, treatment strategies, drug side effects, drug resistance, hepatitis co-infection, epidemiology, and prevention are a few of the topic areas covered at CROI. Now's your chance to hear what's up, from an expert who was there!

Sandy Bartlett

Community Education Coordinator, AIDS Services of Austin